/Companies

Thylacine Biotherapeutics

Miami Beach, US · Founded 2021 · Delaware corporation

Find your way into Thylacine Biotherapeutics

Sign up to see every warm intro you have to Thylacine Biotherapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Thylacine Biotherapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

RG
Robert GraifmanNamed on SEC filing
DG
Daniel GraifmanNamed on SEC filing
AF
Andrew FradkinNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$476K disclosed across 1 round · 2023

▶$476KraisedJan 2023 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert GraifmanDirector
  • Daniel GraifmanExecutive Officer, Director
  • Andrew FradkinDirector
Offering amount
$1M
Amount sold
$476K
Minimum investment
$5K
Sales commissions
$70K
Proceeds to insiders
$100K
Placement agents
Walter Greenblatt & Assoc
First sale
Jan 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Thylacine Biotherapeutics raised?
Thylacine Biotherapeutics has disclosed $476K raised across 1 round.
Where is Thylacine Biotherapeutics headquartered?
Thylacine Biotherapeutics is headquartered in Miami Beach, US.